Pharmaceutical Packaging Market Forecast 2014 2024
-
Upload
visiongain -
Category
Business
-
view
247 -
download
1
description
Transcript of Pharmaceutical Packaging Market Forecast 2014 2024
www.visiongain.com
Contents
1. Report Overview
1.1 Global Pharmaceutical Packaging Market Overview
1.2 Global Pharmaceutical Packaging Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to the Pharmaceutical Packaging Market
2.1 Pharmaceutical Packaging Market Definition
2.2 Pharmaceutical Packaging Market Structure Overview
3. Global Pharmaceutical Packaging Market 2014-2024
3.1 Global Pharmaceutical Packaging Market Forecast 2014-2024
3.2 Drivers and Restraints of the Pharmaceutical Packaging Market
3.2.1 Drivers of the Pharmaceutical Packaging Market
3.2.2 Restraints to the Pharmaceutical Packaging Market
4. Pharmaceutical Packaging Submarkets Forecasts by Material 2014-
2024
4.1 An Overview of the Pharmaceutical Packaging Submarkets by Material2014-2024
4.2 How will the Materials Used for Pharmaceutical Packaging Vary between 2014 and 2024?
www.visiongain.com
Contents
4.3 Flexible Plastic Packaging in the Pharmaceutical Packaging Market 2014-2024
4.3.1 Flexible Plastic Pharmaceutical Packaging Submarket Analysis 2014-2024
4.4 Rigid Plastic Packaging in the Pharmaceutical Packaging Market 2014-2024
4.4.1 Rigid Plastic Pharmaceutical Packaging Submarket Analysis 2014-2024
4.5 Glass Packaging in the Pharmaceutical Packaging Market 2014-2024
4.5.1 Glass Pharmaceutical Packaging Submarket Analysis 2014-2024
4.6 Metal Packaging in the Pharmaceutical Packaging Market 2014-2024
4.6.1 Metal Pharmaceutical Packaging Submarket Analysis 2014-2024
4.7 Paper Packaging in the Pharmaceutical Packaging Market 2014-2024
4.7.1 Paper Pharmaceutical Packaging Submarket Analysis 2014-2024
5. Leading National Pharmaceutical Packaging Market Forecasts 2014-
2024
5.1 Leading National Pharmaceutical Packaging Markets Share Forecast 2014-2024
5.2 The United States of America Pharmaceutical Packaging Market 2014-2024
5.2.1 Drivers & Restraints of the Unites States of America’s Pharmaceutical Packaging
Market
5.2.2 The United States of America Pharmaceutical Packaging Market Analysis 2014-2024
5.2.2.1 How is the US Pharmaceutical Packaging Industry Influenced by its
Pharmaceutical Market?
5.2.2.2 Impact of US Regulations on the Pharmaceutical Packaging Industry
5.2.2.3 How will the Federal Healthcare Reform Affect the US Pharmaceutical
Packaging Market?
5.3 The Japanese Pharmaceutical Packaging Market 2014-2024
5.3.1 Drivers & Restraints of the Japanese Pharmaceutical Packaging Market 2014-2024
5.3.2 The Japanese Pharmaceutical Packaging Market Analysis 2014-2024
5.3.2.1 Will the Japanese Pharmaceutical Packaging Industry Benefit from its Ageing
www.visiongain.com
Contents
and Affluent Population?
5.3.2.2 Will the Economic and Political Situation in Japan Obstruct the Growth its
Pharmaceutical Packaging Industry?
5.3.2.3 Is the Long-lasting Effect of the 2011 Tsunami Still There?
5.3.2.4 Will the High Potential Generic Market in Japan Drive the Growth of the
Japanese Pharmaceutical Packaging Market?
5.4 The Chinese Pharmaceutical Packaging Market 2014-2024
5.4.1 Drivers & Restraints of the Chinese Pharmaceutical Packaging Market
5.4.2 The Chinese Pharmaceutical Packaging Market Analysis 2014-2024
5.4.2.1 How will the Chinese Economic Growth Influence the Pharmaceutical
Packaging Market in China?
5.4.2.2 The Impact of the Chinese Healthcare Reform on its Pharmaceutical
Packaging Market
5.5 The German Pharmaceutical Packaging Market 2014-2024
5.5.1 Drivers & Restraints of the German Pharmaceutical Packaging Industry
5.5.2 The German Pharmaceutical Packaging Market Analysis 2014-2024
5.5.2.1 Germany: The Largest Pharmaceutical Packaging Market in Europe
5.5.2.2 How Policy Changes Affect the Pharmaceutical Packaging Industry in
Germany?
5.6 The French Pharmaceutical Packaging Market 2014-2024
5.6.1 Drivers & Restraints of the French Pharmaceutical Packaging Market
5.6.2 The French Pharmaceutical Packaging Market Analysis 2014-2024
5.7 The Brazilian Pharmaceutical Packaging Market
5.7.1 Drivers & Restraints of the Brazilian Pharmaceutical Packaging Market 2014-2024
5.7.2 The Brazilian Pharmaceutical Packaging Market Analysis 2014-2024
5.7.2.1 Economic Growth: Emerging Middle Class
5.7.2.2 How Government Intervention Influence the Pharmaceutical Packaging
Market in Brazil?
www.visiongain.com
Contents
5.7.2.3 Anti-counterfeiting Pharmaceutical Packaging in Brazil
5.8 The Italian Pharmaceutical Packaging Market 2014-2024
5.8.1 Drivers & Restraints of the Italian Pharmaceutical Packaging Market
5.8.2 The Italian Pharmaceutical Packaging Market Analysis 2014-2024
5.8.2.1 Italy: Large Pharmaceutical Manufacturing Industry
5.8.2.2 The Demographic Structure in Italy
5.8.2.3 The Economic and Political Threats to the Italian Pharmaceutical Packaging
Industry
5.9 The Spanish Pharmaceutical Packaging Market 2014-2024
5.9.1 Drivers and Restraints of the Spanish Pharmaceutical Packaging Market
5.9.2 The Spanish Pharmaceutical Packaging Market Analysis 2014-2024
5.9.2.1 Demographic Factors
5.9.2.2 How does the Government’s Austerity Measures Affect the Spanish
Pharmaceutical Packaging Market?
5.10 The Canadian Pharmaceutical Packaging Market 2014-2024
5.10.1 Drivers and Restraints of the Canadian Pharmaceutical Packaging Market
5.10.2 The Canadian Pharmaceutical Packaging Market Analysis 2014-2024
5.10.2.1 How the Canadian Pharmaceutical Industry Influence the Pharmaceutical
Packaging Industry in Canada?
5.10.2.2 How the Patent Rules in Canada Affect the Canadian Pharmaceutical
Packaging Industry?
5.11 The United Kingdom Pharmaceutical Packaging Market 2014-2024
5.11.1 Drivers & Restraints of the United Kingdom Pharmaceutical Packaging Market
5.11.2 The United Kingdom Pharmaceutical Packaging Market Analysis 2014-2024
5.11.2.1 Demographic Structure in the UK
5.11.2.2 UK’s Reputation of R&D in Pharmaceutical Industry
5.12 The Indian Pharmaceutical Packaging Market 2014-2024
5.12.1 Drivers & Restraints of the Indian Pharmaceutical Packaging Market
www.visiongain.com
Contents
5.12.2 The Indian Pharmaceutical Packaging Market Analysis 2014-2024
5.12.2.1 What will Economic Growth in India Bring to the Indian Pharmaceutical
Packaging Industry?
5.12.2.2 How will Regulations in India Affect the Indian Pharmaceutical Packaging
Industry?
5.13 The Russian Pharmaceutical Packaging Market 2014-2024
5.13.1 Drivers & Restraints of the Russian Pharmaceutical Packaging Market
5.13.2 The Russian Pharmaceutical Packaging Market Analysis 2014-2024
5.13.2.1 Economic and Demographic Factors
5.13.2.2 How do Government Initiatives Affect the Pharmaceutical Packaging
Industry in Russia?
5.14 The Australian Pharmaceutical Packaging Market 2014-2024
5.14.1 Drivers & Restraints of the Australian Pharmaceutical Packaging Market
5.14.2 The Australian Pharmaceutical Packaging Market Analysis 2014-2024
5.14.2.1 Drivers of the Australian Pharmaceutical Packaging Industry
5.14.2.2 How will the Changes in the Australian Healthcare System Affect the
Australian Pharmaceutical Packaging Industry?
5.15 The Rest of the World Pharmaceutical Packaging Market 2014-2024
6. SWOT Analysis of the Pharmaceutical Packaging Market 2014-2024
6.1 Strengths of the Pharmaceutical Packaging Market
6.1.1 Resilient Sector to Macroeconomic Environment
6.1.2 Fast Growing Sector in Developing Countries
6.1.3 Single Use Nature of Products
6.2 Weaknesses of the Pharmaceutical Packaging Market
6.2.1 Pharmaceutical Packaging not able to be Reused or Recycled
6.2.2 Pharmaceutical Packaging Regulation and Traceability Methods Vary Globally
www.visiongain.com
Contents
6.2.3 General Reduction in Healthcare Expenditure by Governments in Developed Countries
6.3 Opportunities in the Pharmaceutical Packaging Market
6.3.1 Ageing Population
6.3.2 The Growth of Blister Packaging
6.3.3 Increasing Demand for Consumer-friendly and Other Sophisticated Packaging Products
6.3.4 Online Printing to Improve Supply Chain Flexibility
6.4 Threats to the Pharmaceutical Packaging Market
6.4.1 Research of Fixed-Dose Combination/Combination Delivery Systems
6.4.2 Government Regulation and Intervention
6.4.3 Cost Pressure on Pharmaceutical Packaging Industry
7. Expert Opinion
7.1 Mr Andrew Love, Vice President Capability Development, Be4ward Ltd
7.1.1 What Significant Changes or Trends are there in the Pharmaceutical Packaging Industry?
7.1.2 Other Countries’ Pharmaceutical Packaging Market
7.1.3 Future Trends of the Industry
7.1.4 Are the Changes in Regulations Limiting Market Potential for Pharmaceutical Packaging?
7.1.5 Trends in the Material Used in Pharmaceutical Packaging Industry
7.1.6 Trends in the Pharmaceutical Packaging Market in Terms of Packaging Type
7.1.7 Challenges and Opportunities Facing the Pharmaceutical Packaging Industry
7.2 Mr. Mike Schaefers, Vice President Global Marketing, West Pharmaceutical Services, Inc.
7.2.1 Which Regions are Experiencing a Major Growth or Decline in their Pharmaceutical
Packaging Spending?
7.2.2 How Important are Emerging Markets?
7.2.3 What is the Trend of Materials Used in the Pharmaceutical Packaging Industry?
7.2.4 Future Market Trend in Terms of Packaging Type
7.2.5 Drivers and Restraints Facing the Pharmaceutical Packaging Market
www.visiongain.com
Contents
7.2.6 Challenges and Opportunities Facing the Pharmaceutical Packaging Market
7.3 Mr. Andreas Neumann, Market Intelligence Manager, Gerresheimer
7.3.1 Which Regions are experiencing a Major Growth or Decline in their Pharmaceutical
Packaging Spending?
7.3.2 How Important are Emerging Markets?
7.3.3 What is the Trend of Materials Used in the Pharmaceutical Packaging Industry?
7.3.4 Future Market Trend in Terms of Packaging Type
7.3.5 Drivers and Restraints Facing the Pharmaceutical Packaging Market
7.3.6 Challenges and Opportunities Facing the Pharmaceutical Packaging Market
7.3.7 Current and Future Trends in the Pharmaceutical Packaging Market
8. Leading Companies in the Pharmaceutical Packaging Market 2014
8.1 Amcor Limited
8.1.1 Amcor Products and Services
8.1.2 Amcor Limited: Global Footprint with Focused Portfolio
8.1.3 Amcor Limited: Early Mover in the Emerging Markets
8.1.4 Amcor Limited M&A Activity
8.1.5 Amcor Limited: Demerger of Amcor Australasia & Packaging Distribution (AAPD)
8.1.6 Amcor Future Outlook
8.2 Aptargroup. Inc.
8.2.1 Aptargroup. Inc. Products & Services
8.2.2 Aptargroup Analysis
8.2.3 Aptar Pharma Analysis: Sales Forecast 2014-2024
8.3 Becton & Dickinson (BD)
8.3.1 Becton & Dickinson Products and Services
8.3.2 Becton & Dickinson M&A Activity
8.3.3 Becton & Dickinson Future Outlook
www.visiongain.com
Contents
8.4 Bemis
8.4.1 Bemis: Products & Services
8.4.2 Bemis Company Inc. Corporate Strategies
8.4.3 Bemis Analysis
8.4.4 Bemis Company Inc. M&A Activity
8.4.5 Bemis Healthcare Packaging Analysis
8.5 Catalent
8.5.1 Catalent Products & Services
8.5.2 Catalent Analysis
8.5.3 Catalent M&A Activity
8.6 Gerresheimer
8.6.1 Gerresheimer: Products & Services
8.6.2 Gerresheimer Analysis
8.6.3 Gerresheimer M&A Activity
8.7 MeadWestvaco Corporation
8.7.1 MeadWestvaco Corporation Products & Services
8.7.2 MeadWestvaco Corporation Analysis
8.7.3 MeadWestvaco Corporation M&A Activity
8.7.4 MeadWestvaco Corporation Discontinued Operations
8.8 Multi Packaging Solutions / Chesapeake
8.8.1 Multi Packaging Solutions / Chesapeake Products & Services
8.8.2 Multi Packaging Solutions / Chesapeake Analysis
8.8.3 Multi Packaging Solutions / Chesapeake M&A Activity
8.9 Owens-Illinois
8.9.1 Owens-Illinois Products & Services
8.9.2 Owens-Illinois Analysis
8.9.3 Owens-Illinois M&A and Discontinued Operations
8.9.4 Owens-Illinois Future Outlook
www.visiongain.com
Contents
8.10 SCHOTT
8.10.1 SCHOTT Products & Services
8.10.2 SCHOTT Pharmaceutical Packaging Analysis
8.10.3 SCHOTT Pharmaceutical Packaging Main Competitors
8.10.4 SCHOTT Future Outlook
8.11 West Pharmaceutical Services
8.11.1 West Pharmaceutical Services Products & Services
8.11.2 West Pharmaceutical Services Analysis
8.12 Other Leading Companies in the Pharmaceutical Packaging Market
9. Conclusion & Recommendations
9.1 Pharmaceutical Packaging Market Overview
9.2 How will the Three Largest Pharmaceutical Packaging Markets Vary over the Forecast Period
2014 – 2024?
9.3 Key Trends in the Pharmaceutical Packaging Market
9.3.1 The Increasing Influence of Anti-counterfeiting Packaging in the Pharmaceutical
Packaging Market
9.3.2 Other Trends in the Pharmaceutical Packaging Industry
9.4 Drivers & Restraints of the Pharmaceutical Packaging Industry
9.5 Global Pharmaceutical Packaging Market Forecast 2014-2024
9.6 Pharmaceutical Submarket Forecast 2014-2024
9.7 Leading National Pharmaceutical Packaging Markets Forecast 2014-2024
9.8 A Summary of the National Pharmaceutical Packaging Market
9.8.1 The United States of America Pharmaceutical Packaging Market
9.8.2 The Japanese Pharmaceutical Packaging Market
9.8.3 The Chinese Pharmaceutical Packaging Market
9.8.4 The Germany Pharmaceutical Packaging Market
www.visiongain.com
Contents
9.8.5 The French Pharmaceutical Packaging Market
9.8.6 The Brazilian Pharmaceutical Packaging Market
9.8.7 The Italian Pharmaceutical Packaging Market
9.8.8 The Spanish Pharmaceutical Packaging Market
9.8.9 The Canadian Pharmaceutical Packaging Market
9.8.10 The United Kingdom Pharmaceutical Packaging Market
9.8.11 The Indian Pharmaceutical Packaging Market
9.8.12 The Russian Pharmaceutical Packaging Market
9.8.13 The Australian Pharmaceutical Packaging Market
9.8.14 The Rest of the World Pharmaceutical Packaging Market
www.visiongain.com Page 83
Pharmaceutical Packaging Market Forecast 2014-2024: Opportunities for Leading Companies in OTC & Non-OTC Pharmaceuticals
Figure 5.24 Italian Government Debt in % of GDP - Quarterly Data 2000-2014
5.9 The Spanish Pharmaceutical Packaging Market 2014-2024
100
105
110
115
120
125
130
135
140
2000Q1 2003Q1 2006Q1 2009Q1 2012Q1
% o
f GDP
Time
Table 5.9 The Spanish Pharmaceutical Packaging Market Forecast 2014-2024 ($billion, AGR %, CAGR %, Cumulative)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2014-24Sales $bn 2.3 2.4 2.5 2.5 2.6 2.6 2.7 2.8 2.8 2.9 3.0 3.1 29.8AGR % 2.3 2.4 2.3 2.4 2.4 2.3 2.5 2.6 2.8 2.9 2.7CAGR (%) 2014-19CAGR (%) 2014-24
2019-242.3 2.72.5
Source: Eurostat 2014; visiongain 2014
Source: visiongain 2014
www.visiongain.com Page 89
Pharmaceutical Packaging Market Forecast 2014-2024: Opportunities for Leading Companies in OTC & Non-OTC Pharmaceuticals
5.10.1 Drivers and Restraints of the Canadian Pharmaceutical Packaging
Market
Figure 5.29 Canadian Pharmaceutical Packaging Market: Drivers and Restraints, 2014-2024
5.10.2 The Canadian Pharmaceutical Packaging Market Analysis 2014-
2024
The Canadian pharmaceutical packaging market is forecasted by visiongain to be worth $2.1 billion in
2014, and will grow to be worth $3.2 billion in 2024. Visiongain expects the Canadian pharmaceutical
packaging market to grow at a CAGR of 4.7% between 2014 and 2024. The growth rate in the second
half of the forecasting period is slightly higher, with a CAGR of 4.7% between 2019 and 2024,
comparing to a CAGR of 4.6% between 2014 and 2019. The Canadian pharmaceutical packaging
industry will experience a decrease in the global market share in the forecast period. It has a market
share of 3.1% in 2014, before dropping to 2.8% in 2019 and to 2.6% in 2024.
• Aging population
• Universal healthcare
• Large pharmaceutical market and pharmaceutical research industry
• Pharmaceutical product spending is Canada’s second largest healthcare expenditure
Drivers Restraints
• Bi-lingual pharmaceutical packaging rules can add to complexity
• Long waiting times means that some Canadians choose to travel to the US for healthcare treatment
• Complex regulatory regime
• Intellectual property laws not very strong
Source: visiongain 2014
www.visiongain.com Page 113
Pharmaceutical Packaging Market Forecast 2014-2024: Opportunities for Leading Companies in OTC & Non-OTC Pharmaceuticals
7. Expert Opinions
7.1 Mr Andrew Love, Vice President Capability Development, Be4ward Ltd
Andrew Love is currently Vice President Capability Development at Be4ward Ltd, assisting a number
of Pharmaceutical clients with packaging management related engagements.
Prior to this, Andrew led GlaxoSmithKline’s (GSK) global packaging design operations until 2009,
where he was responsible for the transformation of their capabilities into a best in class operation. He
recently co-authored a new book, Developing and Sustaining Excellent Packaging Labelling and
Artwork Capabilities. Andrew holds a Masters in Mechanical Engineering and an MBA and he has
worked in the global Pharmaceutical supply chain for more than 20 years
Andrew also writes insightful blog articles at http://andrewrlove.com, and contributes monthly columns
to Pharma IQ.
In August 2014, visiongain interviewed Mr. Andrew Love and would like to take this opportunity to
thank him for his participation.
7.1.1 What Significant Changes or Trends are there in the Pharmaceutical
Packaging Industry?
Visiongain: What significant changes or trends are there in the pharmaceutical packaging industry
since your previous interview with visiongain early this year?
Andrew Love: I do not think there are many. The one that would stand out is the GSK crisis in China
and the concern across the industry about doing businesses in China. But that is not just
pharmaceutical industry specific. Other industries are getting issues there as well. If you go back 3, 4
years ago, everyone is looking at developing countries as the place to focus. I think Russia and China
are both proving very challenging at the moment, but for different reasons. China is because of all of
the concerns around business practices in China under the tightening up by the Chinese authorities.
Russia is more about the assumptions being applied to Russia because of the Ukraine Crisis. So I
think everyone looked at these countries as the place to go but now finding that it is more challenging
than they first thought.
www.visiongain.com Page 138
Pharmaceutical Packaging Market Forecast 2014-2024: Opportunities for Leading Companies in OTC & Non-OTC Pharmaceuticals
Aptar Pharma provides innovative drug delivery solutions to biotechnology, healthcare and
pharmaceutical companies. Aptar Pharma has manufacturing sites in Argentina, China, France,
Germany, India, Switzerland and the USA, providing the global market with more than 1 billion
proprietary drug delivery devices each year. The segment had global sales of $708.8 million in 2013.
There are two divisions under Aptar Pharma: the Consumer Health Care Division and the Prescription
Division. The Consumer Health Care Division provides off-the-shelf and personalised proprietary drug
delivery technologies and services. Application fields include: nasal decongestant, nasal saline,
digestive/gastrointestinal, cough & cols, dermal drug delivery, analgesics, wound treatment, eye care,
ear care and other application fields. The Prescription Division provides innovative delivery solutions
to meet the physician-prescribed sector needs.
8.2.2 Aptargroup Analysis
After reporting a record annual sale of $2.5 billion for 2013, Aptar has seen record quarterly earnings
for the first and second quarters of 2014. Sales for Q1 and Q2 are $676 million and $671 million
respectively. As table 8.9 and figure 8.3 demonstrate, Aptar has seen steady growth in quarterly
sales revenue in the past 2 years in most of its segments.
Table 8.8 Aptar Other Products/Services 2014 (Products, Specification)
Company Division Product Specification Other divisions:
• Aptar Beauty + Home
• Aptar Food +
Beverage
For other divisions’ products
irrelevant to pharmaceutical
packaging, please refer to
the company’s website for
details.
Refer to the company’s website
Table 8.9 Aptar Quarterly Sales Revenue by Segments 2012-2014 ($millions)
2012 2013 2014 2012 2013 2014 2012 2013 2014 2012 2013 2014Aptargroup 592.5 617.6 676.1 577.5 641.4 670.6 589.6 623.6 571.4 637.3Aptar Beauty + Home 377.2 363.5 391.2 369.3 375.0 385.2 358.5 376.1 349.0 373.6Aptar Food + Beverage 75.3 85.3 90.5 75.2 83.5 89.7 75.0 75.3 62.8 79.0Aptar pharma 140.0 168.9 194.3 133.0 182.9 195.7 156.1 172.3 159.6 184.7
N.A.N.A.
Q1 Q2 Q3 Q4
Source: Aptargroup 2014; visiongain 2014
Source: Aptargroup 2014; visiongain 2014